Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 806 results for "michael pearson"

4 - PEARSON JAMES MICHAEL (0001195868) (Reporting)

Form 4 - Statement of changes in beneficial ownership of securities SEC Accession No. 0001140361-16-066708 Filing Date 2016-05-23 2016-05-23 17:15:24 Period of Report 2016-05-19 Filing Date Changed 2016-05-23 Document Format Files ... SEC Filings, 2 days ago

99 images for michael pearson

Computer Dealer News, 1 week ago
Augusta Chronicle, 4 weeks ago
Fortune, 3 weeks ago
Forbes India, 6 days ago
CNBC, 3 weeks ago
Bloomberg TV Canada, 3 weeks ago
Bloomberg, 3 weeks ago
Business Insider, 3 weeks ago
CBC, 4 weeks ago
BBC, 4 weeks ago

Valeant's CEO is heading for a grilling, but it looks like Congress isn't discouraging drug-price hikes

Michael Pearson, Valeant CEO See Also How NASA's groundbreaking work on human blood can predict your reaction to certain drugs Were running out of prescription drugs, and it's not for the reason you think New drugs that could save ...
 Business Insider UK3 weeks ago Valeant CEO Pearson's Compensation Relies Heavily on Now-Underwater Stock  Morningstar.com3 weeks ago J. Michael Pearson, Valeant CEO, tells Congress company acquired drugs, hiked prices  Washington Times4 weeks ago
Business Insider

A murky part of Valeant's business has suddenly caught everyone's attention - and the company can't be happy about it

ReutersOutgoing Valeant CEO, Michael Pearson All at once, everyone wants to know more about the mysterious programs that Valeant Pharmaceuticals uses to help people buy its drugs — patient assistance programs. The programs were mentioned in risk ...
 Business Insider3 weeks ago Everyone going after Valeant is going after the same thing  Business Insider India3 weeks ago
Business Insider UK

Is there a Valeant lurking in Asean?

Valeant Pharmaceuticals International CEO Michael Pearson's fall from grace last month was nasty and brutish. Last summer, the former McKinsey consultant was at the helm of a company that was a stock market darling. The stock skyrocketed nearly ...
 Edge Markets2 weeks ago Morning Read: Warren Buffett calls Valeant enormously flawed, Hollywood discovers science star  MedCity News3 weeks ago BRIEF-Valeant says Michael Pearson 2015 total compensation $143.1 mln  Reuters UK3 weeks ago Wall Street dropped a bomb on Valeant right before the company's Senate hearing  Business Insider UK3 weeks ago
[x]  
Fortune

This Is What Bill Ackman Really Thinks About Valeant's Outgoing CEO

Activist investor Bill Ackman, one of Valeant Pharmaceutical's major investors, wasn't very happy with Michael Pearson, it turns out. A cache of emails released, part of an 818-page document dump provided to a U.S. Senate committee, provided ...
 Fortune2 weeks ago Valeant CEO Pearson to exit, Ackman to join board  Business Standard2 months ago
Business Insider

Bill Ackman tells everyone how he really feels about Michael Pearson

Hedge fund mogul Bill Ackman is such a pill. The activist investor, whose Pershing Square fund has taken a beating on its massive position in Valeant Pharmaceuticals, was a persistent critic of ex-Chief Executive Michael Pearson — slamming him on ...
 New York Post2 weeks ago Bill Doyle's Pershing Exit Adds to Disastrous Quarter for Bill Ackman  TheStreet.com1 week ago Valeant and Herbalife Again Hit Ackman's Pershing Square  TheStreet.com2 weeks ago REPORTS: A key figure in Bill Ackman's Valeant investment is leaving Pershing Square  Business Insider Malaysia2 weeks ago
[x]  
VTDigger.org

Lawmakers Blast Valeant for Price-Gouging Tactics

From left, Valeant's outgoing CEO, J. Michael Pearson; former chief financial officer Howard Schiller; and billionaire investor William Ackman, whose hedge fund holds a large stake in Valeant and controls two seats on its board of directors, are ...
 Continuity Insights3 weeks ago Rep. Pearson running for state Senate in Democratic primary  VTDigger.org1 week ago Munger: Valeant Pharmaceuticals turned out to be a 'sewer'  CNBC3 weeks ago Valeant CEO says company was too  CPhI.cn3 weeks ago
[x]  
Motley Fool

Ex-Valeant CEO might have earned a $2.66B stock payoff. Today? It's zero

Valeant Pharmaceuticals'now-ex CEO Michael Pearson could have been a billionaire more than four times over if his winning streak hadn't come to an ignominious end. Nowbowing out with apologies and mea culpas, Pearson racked up an apparent$140 ...
 FiercePharma2 weeks ago What's Behind Valeant Pharmaceuticals Soaring 10% Today?  Motley Fool3 weeks ago
CNBC

Warren Buffett: Don't run a company like Michael Pearson ran Valeant

The answer ignored a request from New York Times writer Andrew Ross Sorkin to discuss the effect of Coca-Cola on global public health without Buffett touching on his own diet. "Pearson ... he certainly seemed like the sort of person who forged all ...
 Equilibrio Informativo2 weeks ago VALEANT'S NEW CEO : I'm not in it for the money  4 Traders2 weeks ago Cramer Remix: Biggest surprise for Valeant's new CEO  Yahoo! 7 Finance2 weeks ago Cramer: Valeant CEO's biggest surprise  CNBC2 weeks ago
[x]  
Business Insider

The disastrous Valeant document everyone's been waiting for is finally here

By 41 minutes ago (Reuters) Michael Pearson, former Valeant CEO After months of delays, a Senate hearing, and a precipitous stock fall, Valeant Pharmaceuticals finally filedtheir annual 10-k report to the SEC Friday ...
 Yahoo! Finance3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - michael pearson
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less